Painless Myocardial Ischemia in Diabetic Patients.

Completed

• Conditions: Painless Myocardial Ischemia

• Registration Number: NCT04071808
• Lead Sponsor: Second Hospital of Shanxi Medical University

Brief Summary

This study aims to investigate the relationship between the concentrations of blood orphanin, norepinephrine and the morbidity of painless myocardial ischemia in patients with diabetes mellitus. Hopefully, the biomarker(s) in the blood of diabetic patients can be found for screening high risk patients in the diabetes sufferers to prevent the painless myocardial ischemia.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-08-26
• Study First Submitted QC: 2019-08-26
• Study First Posted: 2019-08-28
• Study Start: 2019-10-01
• Primary Completion: 2019-12-30
• Study Completion: 2020-03-01
• Status Verified: 2022-04
• Last Update Submitted: 2022-04-18
• Last Update Posted: 2022-04-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Subject has diabetes

Exclusion Criteria

• History of myocardial ischemia
• Symptoms of myocardial ischemia（ECG changes except）

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood orphanin content	24 hours	Blood orphanin levels in painless diabetic patients with myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy.
Blood norepinephrine content	24 hours	Blood norepinephrine levels in diabetic patients with painless myocardial ischemia requiring interventional therapy and diabetic patients without interventional therapy

Trial Locations

Locations (1)

Second of Shanxi Medical University; 🇨🇳 Taiyuan, Shanxi, China